<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Substantial evidence implicates the neuropeptide substance P (SP) in mucosal immunoinflammatory responses </plain></SENT>
<SENT sid="1" pm="."><plain>Autoradiographic studies have suggested a disturbance in SP receptor expression in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) </plain></SENT>
<SENT sid="2" pm="."><plain>AIMS: Because of technical limitations such as poor cellular resolution with autoradiography, we used molecular methods to specifically localise the cellular expression of the neurokinin-1 receptor (NK-1R) in IBD colon, and to quantitate NK-1R <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels therein </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In situ hybridisation and immunohistochemistry were used to localise NK-1R <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein, respectively, in <z:mpath ids='MPATH_458'>normal</z:mpath>, <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC), and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD) colonic resections </plain></SENT>
<SENT sid="4" pm="."><plain>NK-1R <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of <z:mpath ids='MPATH_458'>normal</z:mpath>, UC, and CD mucosal biopsies were quantitated by competitive reverse transcription-polymerase chain reaction </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: NK-1R expression was localised to lamina propria mononuclear cells, epithelium, submucosal vasculature, smooth muscle, and myenteric plexus of <z:mpath ids='MPATH_458'>normal</z:mpath> and IBD colon </plain></SENT>
<SENT sid="6" pm="."><plain>No ectopic NK-1R expression was observed in IBD </plain></SENT>
<SENT sid="7" pm="."><plain>However, we found increased numbers of NK-1R expressing lymphoid cells in IBD tissue, aberrant negative epithelial expression of NK-1R in UC, and increased expression of NK-1R in CD myenteric plexus </plain></SENT>
<SENT sid="8" pm="."><plain>Quantitation of NK-1R <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in IBD colonic mucosal biopsies revealed marked upregulation of NK-1R <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels compared with non-inflamed mucosal expression levels (p&lt;0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This report demonstrates the strategic localisation and upregulation of NK-1R expression in IBD colon, and thereby suggests the involvement of substance P in the pathophysiological symptoms of IBD </plain></SENT>
</text></document>